142 related articles for article (PubMed ID: 35959349)
41. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
43. Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network.
Wei L; Gu W; Hu L; Wang K; Huang H; Shen Y
Crit Rev Eukaryot Gene Expr; 2022; 32(6):57-68. PubMed ID: 35997118
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
45. JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis.
Zuo Y; Ma M; Wen Y; Chang L; Qu C
Clin Transl Oncol; 2023 Jul; 25(7):2192-2203. PubMed ID: 36862282
[TBL] [Abstract][Full Text] [Related]
46. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
[TBL] [Abstract][Full Text] [Related]
47. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of lncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression.
Liu J; Zhang J; Hu Y; Zou H; Zhang X; Hu X
J Gene Med; 2021 Jan; 23(1):e3281. PubMed ID: 33025624
[TBL] [Abstract][Full Text] [Related]
49. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of the long noncoding RNA TRHDE-AS1 inhibits the progression of lung cancer via the miRNA-103/KLF4 axis.
Zhuan B; Lu Y; Chen Q; Zhao X; Li P; Yuan Q; Yang Z
J Cell Biochem; 2019 Oct; 120(10):17616-17624. PubMed ID: 31119790
[TBL] [Abstract][Full Text] [Related]
51. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis.
Liu L; Zhao H; He HH; Huang J; Xu YY; Li XL; Wu Y; Wang J; Zhu YB
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12748-12756. PubMed ID: 33378023
[TBL] [Abstract][Full Text] [Related]
54. lncRNA PDCD4-AS1 Promotes the Progression of Glioma by Regulating miR-30b-3p/METTL7B Signaling.
Li Z; Song Y; Zhang J
Oxid Med Cell Longev; 2023; 2023():3492480. PubMed ID: 37151605
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
56. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.
Yuan J; Song Y; Pan W; Li Y; Xu Y; Xie M; Shen Y; Zhang N; Liu J; Hua H; Wang B; An C; Yang M
Oncogene; 2020 Oct; 39(43):6664-6676. PubMed ID: 32939012
[TBL] [Abstract][Full Text] [Related]
57. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
Wu D; Sun J; Wang H; Ma C
Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
[TBL] [Abstract][Full Text] [Related]
58. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
Xu F; Li H; Hu C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
[TBL] [Abstract][Full Text] [Related]
59. RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway.
Ayoufu A; Paierhati P; Qiao L; Zhang N; Abudukeremu M
Thorac Cancer; 2023 Aug; 14(24):2504-2514. PubMed ID: 37429610
[TBL] [Abstract][Full Text] [Related]
60. NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation.
Xiang T; Li Y; Liu G; Li X
J Cell Mol Med; 2024 May; 28(10):e18360. PubMed ID: 38785199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
